| Methods:To investigate the motherland of modern medicine’s understanding of osteoporosis, BSHX law principle of treating osteoporosis deficiency of blood stasis, and based on this principle of selection of soups Young Bushenhuoxue basis of this prescription as a treatment prescription. Detailed clinical trials, in experiments using randomized controlled methods, one for the treatment group, the Young Bushenhuoxue be oral decoction; between two groups of a control group, to be oral medicine Caltrate D, after treatment, by observing two groups of patients before symptoms, signs and changes in the laboratory tests, the rationality of the system evaluation Bushenhuoxue law argumentation Young Bushenhuoxue soup in the treatment of osteoporosis in the treatment of blood stasis kidney efficacy and safety, expand the treatment of osteoporosis new ideas, new methods for the treatment of osteoporosis providedMethods:A randomized controlled clinical studies and literature are two different approaches taken in this article, a review of modern medicine and Chinese medicine understanding of osteoporosis through literature research systems, and lay the theoretical foundation for this study Randomized controlled clinical trials adopted methods included50patients, are in line with clinical osteoporosis, kidney and blood stasis syndrome, two groups of25cases. Treatment group received oral Young Bushenhuoxue soup decoction, one dose a day, three times a day, each200ml treatment; control group Caltrate D to oral tablets,600mg, once daily treatment, a course of treatment,6weeks. After treatment groups were compared changes in symptoms, signs and laboratory tests for osteoporosis-related indicators such as bone mineral density, serum calcium level changes come after careful statistical data, the use of statistical software in statistical terms SPSS17.0analysis.Results:The two groups were observed after treatment of the data obtained after statistical analysis the following results: 1, the symptoms and signs:the treatment group and the control group were improved in the treatment group and the control group was92.00%effective with64.00percent, in terms of symptoms and signs of improvement in the treatment group than the control group (P<0.05). Clinical efficacy:clinical efficacy by comparing two groups of patients before and after treatment, the more obvious differences were found between the treatment groups were also more significant, indicating that the two drugs for the improvement of clinical symptoms above has a good effect, but the effect has differences. Markedly effective rate of48.0%in the treatment group, the total effective rate was92.0%, effective rate of the control group12.0%, total effective rate was64.0%, description of the two drugs in improving symptoms in patients with good effect; After treatment, the treatment group and the control group there was significant difference (P<0.05), is superior to the treatment group, indicating improvement in clinical symptoms in the treatment group than the control group of patients.2, bone mineral density (BMD) check indicator:After a treatment group and the control group were elevated bone mineral density of water, the treatment group was significantly more improved bone density levels, syndromes:the treatment group syndromes treatment effective rate of96.0%in the treatment group syndromes treatment effective rate of60.0%, the difference was significant, the treatment group was superior, indicating that the treatment group than the control group in terms of improving the efficacy of TCM syndrome patients3, serum calcium (Ca) check indicator:After treatment, serum calcium were increased between the two groups, there was no significant difference (P<0.05) between the two groups. Serum calcium:serum calcium levels before and after treatment comparison groups were significantly different, with statistical improved in the clinical part of a safe, effective treatment, the application of broad prospects for further in-depth study of meaning. |
PDF Full Text Request